Gilead Sciences, Inc. (GILD)
144.99
-0.22
(-0.15%)
USD |
NASDAQ |
Mar 13, 16:00
144.89
-0.10
(-0.07%)
Pre-Market: 20:00
Gilead Sciences Total Assets (Quarterly) : 59.02B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.59B |
| Johnson & Johnson | 199.21B |
| Eli Lilly & Co. | 112.48B |
| Arcellx, Inc. | 603.99M |
| Moderna, Inc. | 12.34B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.40B |
| Shareholders Equity (Quarterly) | 22.70B |
| Debt to Equity Ratio | 1.125 |
| Current Ratio | 1.553 |
| Net Debt Paydown Yield | -0.30% |